Amlodipine
ATC C08CA01 · WHO DDD 5 mg (oral) · 5 mg tablet or capsule
Class: Calcium channel blockers. ATC code C08CA01 stands for "amlodipine" in the WHO index, whose DDD is 5 mg by the oral route [1].
Amlodipine is sold as capsules in France and as tablets in Spain and the United Kingdom. [2]
WHO Model List of Essential Medicines 2025: listed, core list [3].
Indications on the WHO list (1)
- Essential hypertension · core list · 12. Cardiovascular medicines 12.3. Antihypertensive medicines · first added 2005
The WHO electronic list states that the 2025 PDF lists are binding: adults’ list, children’s list.
| Country | Packs | Kind of figure | Cost per DDD | Annual cost at the WHO standard dose |
|---|---|---|---|---|
| France | 29 | List price | €0.12 to €0.13 | €43.88 to €49.03 |
| Spain | 32 | List price | €0.04 to €0.08 | €15.21 to €30.42 |
| United Kingdom | 1 | Reimbursement tariff | €0.03 | €10.30 £8.73 |
Names, authorisations and literature
Trade names (38)
- France (13)
- AMLODIPINE ALMUS, AMLODIPINE ARROW, AMLODIPINE BIOGARAN, AMLODIPINE CRISTERS, AMLODIPINE EG, AMLODIPINE EVOLUGEN PHARMA, AMLODIPINE KRKA D.D, AMLODIPINE SANDOZ, AMLODIPINE TEVA, AMLODIPINE VIATRIS, AMLODIPINE ZENTIVA, AMLODIPINE ZYDUS, AMLOR [5]
- Spain (25)
- AMLODIPINO ALTER, AMLODIPINO ALMUS, AMLODIPINO AUROVITAS, AMLODIPINO BD-MABO, AMLODIPINO BLUEFISH, AMLODIPINO CINFA, AMLODIPINO COMBIX, AMLODIPINO KERN PHARMA, AMLODIPINO MABO, AMLODIPINO NORMON, AMLODIPINO ORTODROL, AMLODIPINO PENSA PHARMA, AMLODIPINO RATIOPHARM, AMLODIPINO SANDOZ, AMLODIPINO STADA, AMLODIPINO STADA GENERICOS, AMLODIPINO TAD, AMLODIPINO TARBIS FARMA, AMLODIPINO TECNIGEN, AMLODIPINO TEVA-RATIOPHARM, AMLODIPINO TEVAGEN, AMLODIPINO VIR, AMLODIPINO VIR-PHARMA, ASTUDAL, ZABART [6]
Links lead to the official product page: the EPAR for the European Union, the public medicines database for France, the CIMA summary of product characteristics for Spain, the dm+d for the United Kingdom. An asterisk marks a name taken from the DysNet register only.
European public assessment reports, EPAR (0)
The European Medicines Agency's list holds no medicine with ATC code C08CA01: this medicine has no EPAR [7].
Literature (PubMed, 7,170 papers)
PubMed counts 7,170 papers on this medicine [8]. The selection gives the most recent of each type; the Method page says how it is made. See the search in PubMed ↗
Cochrane reviews (5)
- Padhani ZA, et al. Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia. Cochrane Database Syst Rev. 2023. PubMed 37975597 ↗ doi ↗
- Sadaf A, et al. Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia. Cochrane Database Syst Rev. 2018. PubMed 29998494 ↗ doi ↗
- Ghamami N, et al. Time course for blood pressure lowering of dihydropyridine calcium channel blockers. Cochrane Database Syst Rev. 2014. PubMed 25173808 ↗ doi ↗
- Phillips MF, et al. Calcium antagonists for Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2008. PubMed 18843663 ↗ doi ↗
- Srisurapanont M, et al. Treatment for amphetamine dependence and abuse. Cochrane Database Syst Rev. 2001. PubMed 11687171 ↗ doi ↗
Systematic reviews and meta-analyses (120)
- Mariowska A, et al. Fatal amlodypine overdose: forensic and clinical features - a systematic review. Leg Med (Tokyo). 2026. PubMed 42430979 ↗ doi ↗
- Jiang J, et al. Hypertension and myocardial fibrosis: A systematic review and meta-analysis. Clin Radiol. 2026. PubMed 42296937 ↗ doi ↗
- Hernández-Gago Y, et al. Dosing Strategies for High-Alert Medications in Obese Pediatric Patients: A Systematic Review. Pharmaceuticals (Basel). 2026. PubMed 42198440 ↗ doi ↗
- Pintaningrum Y, et al. Amlodipine monotherapy vs. amlodipine-ARB combination therapy as first-line treatment for primary hypertension: a systematic review and meta-analysis. Front Cardiovasc Med. 2026. PubMed 42099785 ↗ doi ↗
- Tang W, et al. Reversal of left ventricular hypertrophy with sacubitril/valsartan vs. standard antihypertensive agents in hypertension: a systematic review and network meta-analysis. Front Cardiovasc Med. 2026. PubMed 42058496 ↗ doi ↗
Practice guidelines (4)
- Volpe M, et al. Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform. High Blood Press Cardiovasc Prev. 2017. PubMed 29086364 ↗ doi ↗
- Taylor SS, et al. ISFM Consensus Guidelines on the Diagnosis and Management of Hypertension in Cats. J Feline Med Surg. 2017. PubMed 28245741 ↗ doi ↗
- Wang JG, et al. Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement from the Asian Pacific Heart Association. Hypertens Res. 2011. PubMed 21228778 ↗ doi ↗
Health technology assessments (2)
The opinions of the assessment bodies of the pilot countries and of Germany, with a link to each opinion. The status shown is the one each body publishes.
France, HAS Transparency Committee (1)
SMR: actual clinical benefit. ASMR: improvement in actual clinical benefit, from I (major) to V (none). Opinions taken from the BDPM [5].
- CT-15535 · 9 November 2016 · Renouvellement d'inscription (CT) · SMR Important · AMLOR
Wording of the opinion, in French
SMR : Le service médical rendu par AMLOR reste important dans les indications de l’AMM.
England, NICE (0)
NICE has published no technology appraisal that names this medicine among the technologies appraised [9].
Scotland, SMC (1)
- SMC 350/07 · 12 March 2007 · amlodipine besylate/valsartan (Exforge®) · Abbreviated
Indication
For patients whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.
- SMC advice [10]
Germany, G-BA (0)
The G-BA has run no early benefit assessment (AMNOG) of this medicine on its own [11].
Spain, AEMPS therapeutic positioning reports (0)
The AEMPS database of therapeutic positioning reports holds no report on this medicine [12].
How the figure is computed
Example, France: the pack AMLODIPINE ALMUS 5 mg, gélule, plaquette(s) PVC PVDC aluminium de 90 gélule(s), costs €10.82. It holds 450 mg, which is 90 DDD. The cost per DDD is €10.82 ÷ 90 = €0.12, and the annual cost at the WHO standard dose, list price, is that cost × 365 = €43.88.
France
Public price in France, including VAT and the per-pack dispensing fee. Source [5], read on 9 October 2026. ATC match: through the active substance (BDPM substance code), since the BDPM gives no ATC code.
Show the 29 packs
| Product | Pack | Price | DDD per pack | Cost per DDD | Annual cost at the WHO standard dose | Source line |
|---|---|---|---|---|---|---|
| AMLODIPINE ALMUS 5 mg, géluleBIOGARAN | plaquette(s) PVC PVDC aluminium de 90 gélule(s) | €10.82 | 90 | €0.12 | €43.88 | CIS 62042102 / CIP13 3400937976770substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLOR 5 mg, géluleVIATRIS UP | plaquette(s) PVC PVDC aluminium de 90 gélule(s) | €10.82 | 90 | €0.12 | €43.88 | CIS 63458349 / CIP13 3400937243711substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE ZYDUS 5 mg, géluleZYDUS FRANCE | plaquette(s) PVC PVDC aluminium de 90 gélule(s) | €10.82 | 90 | €0.12 | €43.88 | CIS 63566442 / CIP13 3400937915748substance code 93748 (AMLODIPINE (BÉSILATE D')) in CIS_COMPO_bdpm |
| AMLODIPINE EG 5 mg, géluleEG LABO - LABORATOIRES EUROGENERICS | plaquette(s) PVC-Aluminium de 90 gélule(s) | €10.82 | 90 | €0.12 | €43.88 | CIS 63811710 / CIP13 3400938150629substance code 93748 (AMLODIPINE (BÉSILATE D')) in CIS_COMPO_bdpm |
| AMLODIPINE VIATRIS 5 mg, géluleVIATRIS SANTE | plaquette(s) PVC polyéthylène PVDC aluminium de 90 gélule(s) | €10.82 | 90 | €0.12 | €43.88 | CIS 65254879 / CIP13 3400937439831substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE SANDOZ 5 mg, géluleSANDOZ | plaquette(s) PVC PVDC TE (thermo-élastique) aluminium de 90 gélule(s) | €10.82 | 90 | €0.12 | €43.88 | CIS 65681660 / CIP13 3400937844109substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE BIOGARAN 5 mg, géluleBIOGARAN | plaquette(s) PVC PVDC aluminium de 90 gélule(s) | €10.82 | 90 | €0.12 | €43.88 | CIS 65728601 / CIP13 3400937977722substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE ARROW 5 mg, géluleARROW GENERIQUES | plaquette(s) PVC aluminium de 90 gélule(s) | €10.82 | 90 | €0.12 | €43.88 | CIS 66340498 / CIP13 3400938073584substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE KRKA D.D 5 mg, comprimé sécableKRKA (SLOVENIE) | plaquette(s) OPA : polyamide orienté aluminium PVC de 90 comprimé(s) | €10.82 | 90 | €0.12 | €43.88 | CIS 68141192 / CIP13 3400930272794substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE EVOLUGEN PHARMA 5 mg, géluleEVOLUPHARM | plaquette(s) thermoformée(s) PVC PVDC aluminium de 90 gélule(s) | €10.82 | 90 | €0.12 | €43.88 | CIS 68329212 / CIP13 3400926617929substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE TEVA 5 mg, géluleTEVA SANTE | plaquette(s) thermoformée(s) PVC PVDC aluminium de 90 gélule(s) | €10.82 | 90 | €0.12 | €43.88 | CIS 68653367 / CIP13 3400937743570substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE ZENTIVA 5 mg, géluleZENTIVA FRANCE | plaquette(s) PVC PVDC aluminium de 90 gélule(s) | €10.82 | 90 | €0.12 | €43.88 | CIS 69586423 / CIP13 3400937712644substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE CRISTERS 5 mg, géluleCRISTERS | plaquette(s) thermoformée(s) PVC PVDC aluminium de 90 gélule(s) | €10.82 | 90 | €0.12 | €43.88 | CIS 69735867 / CIP13 3400939674704substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE ALMUS 5 mg, géluleBIOGARAN | plaquette(s) PVC PVDC aluminium de 30 gélule(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 62042102 / CIP13 3400937976602substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLOR 5 mg, géluleVIATRIS UP | plaquette(s) PVC PVDC aluminium de 30 gélule(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 63458349 / CIP13 3400933313586substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE ZYDUS 5 mg, géluleZYDUS FRANCE | plaquette(s) PVC PVDC aluminium de 30 gélule(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 63566442 / CIP13 3400937915687substance code 93748 (AMLODIPINE (BÉSILATE D')) in CIS_COMPO_bdpm |
| AMLODIPINE EG 5 mg, géluleEG LABO - LABORATOIRES EUROGENERICS | plaquette(s) PVC-Aluminium de 30 gélule(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 63811710 / CIP13 3400937944892substance code 93748 (AMLODIPINE (BÉSILATE D')) in CIS_COMPO_bdpm |
| AMLODIPINE VIATRIS 5 mg, géluleVIATRIS SANTE | plaquette(s) PVC polyéthylène PVDC aluminium de 30 gélule(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 65254879 / CIP13 3400937439602substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE VIATRIS 5 mg, géluleVIATRIS SANTE | pilulier(s) polyéthylène haute densité (PEHD) de 30 gélule(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 65254879 / CIP13 3400937440141substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE SANDOZ 5 mg, géluleSANDOZ | plaquette(s) PVC PVDC TE (thermo-élastique) aluminium de 30 gélule(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 65681660 / CIP13 3400937844048substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE BIOGARAN 5 mg, géluleBIOGARAN | flacon(s) polyéthylène haute densité (PEHD) de 30 gélule(s) avec fermeture de sécurité enfant | €4.03 | 30 | €0.13 | €49.03 | CIS 65728601 / CIP13 3400930117163substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE BIOGARAN 5 mg, géluleBIOGARAN | plaquette(s) PVC PVDC aluminium de 30 gélule(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 65728601 / CIP13 3400937977661substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE ARROW 5 mg, géluleARROW GENERIQUES | flacon(s) polyéthylène haute densité (PEHD) de 30 gélule(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 66340498 / CIP13 3400930246986substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE ARROW 5 mg, géluleARROW GENERIQUES | plaquette(s) PVC aluminium de 30 gélule(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 66340498 / CIP13 3400937831031substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE KRKA D.D 5 mg, comprimé sécableKRKA (SLOVENIE) | plaquette(s) OPA : polyamide orienté aluminium PVC de 30 comprimé(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 68141192 / CIP13 3400930272787substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE EVOLUGEN PHARMA 5 mg, géluleEVOLUPHARM | plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 gélule(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 68329212 / CIP13 3400926617578substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE TEVA 5 mg, géluleTEVA SANTE | plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 gélule(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 68653367 / CIP13 3400937349550substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE ZENTIVA 5 mg, géluleZENTIVA FRANCE | plaquette(s) PVC PVDC aluminium de 30 gélule(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 69586423 / CIP13 3400937694681substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
| AMLODIPINE CRISTERS 5 mg, géluleCRISTERS | plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 gélule(s) | €4.03 | 30 | €0.13 | €49.03 | CIS 69735867 / CIP13 3400939674643substance code 93748 (BÉSILATE D'AMLODIPINE) in CIS_COMPO_bdpm |
Spain
Retail price including VAT (PVP IVA). Source [13][6], read on 9 October 2026. ATC match: ATC code of each national code, checked in CIMA.
Show the 32 packs
| Product | Pack | Price | DDD per pack | Cost per DDD | Annual cost at the WHO standard dose | Source line |
|---|---|---|---|---|---|---|
| AMLODIPINO CINFA 5MG 30 COMPRIMIDOS EFGCINFA S.A. | 30 COMPRIMIDOS | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 653397AEMPS CIMA, registration 65460 |
| AMLODIPINO NORMON 5 mg Comprimidos, 30 comprimidosNORMON S.A. | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 658218AEMPS CIMA, registration 68310 |
| AMLODIPINO RATIOPHARM 5 mg comprimidos , 30 comprimidosTEVA PHARMA, S.L.U | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 658394AEMPS CIMA, registration 68425 |
| AMLODIPINO SANDOZ 5 mg comprimidos, 30 comprimidosSANDOZ FARMACEUTICA, S.A | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 658980AEMPS CIMA, registration 68760 |
| AMLODIPINO TECNIGEN 5 mg comprimidos, 30 comprimidosTECNIMEDE ESPAÑA INDUSTRIA FARMACEUTICA S.A. | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 659675AEMPS CIMA, registration 69168 |
| AMLODIPINO ORTODROL 5 MG COMPRIMIDOS EFG, 30 comprimidosINDUSTRIA QUIMICA Y FARMACEUTICA VIR, S.A. | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 660982AEMPS CIMA, registration 69812 |
| ZABART 5 mg comprimidos , 30 comprimidosABABOR PHARMACEUTICALS, S.L. | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 661214AEMPS CIMA, registration 69939 |
| AMLODIPINO VIR-PHARMA 5 mg COMPRIMIDOS , 30 comprimidosINDUSTRIA QUIMICA Y FARMACEUTICA VIR, S.A. | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 661281AEMPS CIMA, registration 69962 |
| AMLODIPINO ALMUS 5 mg comprimidos , 30 comprimidosALMUS FARMACEUTICA, S.A.U. | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 662707AEMPS CIMA, registration 70750 |
| ASTUDAL 5MG 30 COMPRIMIDOSALMIRALL, S.A. | 30 COMPRIMIDOS | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 665141AEMPS CIMA, registration 59161 |
| AMLODIPINO COMBIX 5 mg comprimidos , 30 comprimidosCOMBIX, S.L.U | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 672405AEMPS CIMA, registration 72813 |
| AMLODIPINO TEVAGEN 5 mg COMPRIMIDOS EFG, 30 comprimidosTEVA PHARMA, S.L.U | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 688857AEMPS CIMA, registration 75709 |
| AMLODIPINO STADA GENERICOS 5 MG COMPRIMIDOS EFG , 30 comprimidosSTADA, S.L | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 705013AEMPS CIMA, registration 79471 |
| AMLODIPINO AUROVITAS 5 MG COMPRIMIDOS EFG, 30 comprimidosAUROVITAS SPAIN, S.A.U | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 714328AEMPS CIMA, registration 81644 |
| AMLODIPINO PENSA PHARMA 5 MG COMPRIMIDOS EFG, 30 comprimidosTOWA PHARMACEUTICAL, S.A. | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 726154AEMPS CIMA, registration 84264 |
| AMLODIPINO TARBIS FARMA 5 MG COMPRIMIDOS EFG, 30 comprimidosTARBIS FARMA, S.L. | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 727932AEMPS CIMA, registration 84862 |
| AMLODIPINO MABO 5 MG COMPRIMIDOS EFG, 30 comprimidosMABO-FARMA, S.A. | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 729620AEMPS CIMA, registration 85522 |
| AMLODIPINO TAD 5 MG COMPRIMIDOS EFG, 30 comprimidosKRKA FARMACEUTICA, S.L. | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 758066AEMPS CIMA, registration 87992 |
| AMLODIPINO TEVA-RATIOPHARM 5 MG COMPRIMIDOS EFG, 30 comprimidosTEVA PHARMA, S.L.U | 30 comprimidos | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 769567AEMPS CIMA, registration 90902 |
| AMLODIPINO KERN PHARMA 5MG 30 COMP EFGKERN PHARMA, S.L. | 30 COMP | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 862623AEMPS CIMA, registration 65466 |
| AMLODIPINO ALTER 5MG 30 COMPRIMIDOSALTER S.A. | 30 COMPRIMIDOS | €1.25 | 30 | €0.04 | €15.21 | Código Nacional 870337AEMPS CIMA, registration 65082 |
| AMLODIPINO VIR 5 mg comprimidos , 28 comprimidosINDUSTRIA QUIMICA Y FARMACEUTICA VIR, S.A. | 28 comprimidos | €2.01 | 28 | €0.07 | €26.20 | Código Nacional 658403AEMPS CIMA, registration 68433 |
| AMLODIPINO NORMON 5 mg COMPRIMIDOS EFG, 28 comprimidosNORMON S.A. | 28 comprimidos | €2.01 | 28 | €0.07 | €26.20 | Código Nacional 744180AEMPS CIMA, registration 68310 |
| AMLODIPINO ALTER 5 mg COMPRIMIDOS EFG, 28 comprimidosALTER S.A. | 28 comprimidos | €2.01 | 28 | €0.07 | €26.20 | Código Nacional 762917AEMPS CIMA, registration 65082 |
| AMLODIPINO STADA 5 MG COMPRIMIDOS EFG, 28 comprimidosSTADA, S.L | 28 comprimidos | €2.01 | 28 | €0.07 | €26.20 | Código Nacional 763549AEMPS CIMA, registration 79471 |
| AMLODIPINO BLUEFISH 5 mg COMPRIMIDOS EFG, 28 comprimidosBLUEFISH PHARMA, S.L.U | 28 comprimidos | €2.01 | 28 | €0.07 | €26.20 | Código Nacional 764110AEMPS CIMA, registration 72686 |
| ZABART 5 mg COMPRIMIDOS EFG, 28 comprimidosABABOR PHARMACEUTICALS, S.L. | 28 comprimidos | €2.01 | 28 | €0.07 | €26.20 | Código Nacional 764551AEMPS CIMA, registration 69939 |
| AMLODIPINO TAD 5 MG COMPRIMIDOS EFG, 28 comprimidosKRKA FARMACEUTICA, S.L. | 28 comprimidos | €2.01 | 28 | €0.07 | €26.20 | Código Nacional 765717AEMPS CIMA, registration 87992 |
| AMLODIPINO KERN PHARMA 5 mg COMPRIMIDOS EFG, 28 comprimidosKERN PHARMA, S.L. | 28 comprimidos | €2.01 | 28 | €0.07 | €26.20 | Código Nacional 766764AEMPS CIMA, registration 65466 |
| AMLODIPINO TECNIGEN 5 mg COMPRIMIDOS EFG, 28 comprimidosTECNIMEDE ESPAÑA INDUSTRIA FARMACEUTICA S.A. | 28 comprimidos | €2.01 | 28 | €0.07 | €26.20 | Código Nacional 768114AEMPS CIMA, registration 69168 |
| AMLODIPINO CINFA 5 mg COMPRIMIDOS EFG, 28 comprimidosCINFA S.A. | 28 comprimidos | €2.01 | 28 | €0.07 | €26.20 | Código Nacional 768255AEMPS CIMA, registration 65460 |
| AMLODIPINO BD-MABO 5 mg comprimidos bucodispersables , 30 comprimidosMABO-FARMA, S.A. | 30 comprimidos | €2.50 | 30 | €0.08 | €30.42 | Código Nacional 664156AEMPS CIMA, registration 71580 |
United Kingdom
Drug Tariff basic price paid to the pharmacy, excluding VAT (Part VIIIA Category M). Source [14][15], read on 9 October 2026. ATC match: ATC code of the virtual product (VMP) in the dm+d.
Show the 1 pack
| Product | Pack | Price | DDD per pack | Cost per DDD | Annual cost at the WHO standard dose | Source line |
|---|---|---|---|---|---|---|
| Amlodipine 5mg tablets | 28 tablet | £0.67 | 28 | £0.02 | £8.73€10.30 | VMPP SNOMED 995011000001102dm+d browser, VMP 15 |
References
- WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2026 [Internet]. Oslo: Norwegian Institute of Public Health; [updated 2026 Jan 20; cited 2026 Oct 9]. Available from: https://atcddd.fhi.no/atc_ddd_index/
- WHO Collaborating Centre for Drug Statistics Methodology. DDD: definition and general considerations [Internet]. Oslo: Norwegian Institute of Public Health; [cited 2026 Oct 9]. Available from: https://atcddd.fhi.no/ddd/
- World Health Organization. Electronic Essential Medicines List (eEML) [Internet]. Geneva: WHO; [cited 2026 Oct 9]. Available from: https://list.essentialmeds.org/
- European Central Bank. Euro foreign exchange reference rates, 9 October 2026 [Internet]. Frankfurt am Main: ECB; 2026 [cited 2026 Oct 9]. Available from: https://www.ecb.europa.eu/stats/policy_and_exchange_rates/euro_reference_exchange_rates/html/index.en.html
- Base de données publique des médicaments [Internet]. Paris: Ministère du Travail, de la Santé, des Solidarités et des Familles; 2026 [updated 2026 Oct 8; cited 2026 Oct 9]. Available from: https://base-donnees-publique.medicaments.gouv.fr/telechargement
- Agencia Española de Medicamentos y Productos Sanitarios. CIMA: Centro de información de medicamentos [Internet]. Madrid: AEMPS; [cited 2026 Oct 9]. Available from: https://cima.aemps.es/cima/
- European Medicines Agency. Download medicine data [Internet]. Amsterdam: EMA; 2026 [updated 2026 Oct 9; cited 2026 Oct 9]. Available from: https://www.ema.europa.eu/en/medicines/download-medicine-data
- PubMed [Internet]. Bethesda (MD): National Library of Medicine (US); [cited 2026 Oct 9]. Available from: https://pubmed.ncbi.nlm.nih.gov/
- National Institute for Health and Care Excellence. Technology appraisal guidance [Internet]. London: NICE; [cited 2026 Oct 9]. Available from: https://www.nice.org.uk/guidance/published?ngt=Technology%20appraisal%20guidance
- Scottish Medicines Consortium. Medicines advice [Internet]. Glasgow: SMC; [cited 2026 Oct 9]. Available from: https://scottishmedicines.org.uk/medicines-advice/
- Gemeinsamer Bundesausschuss. Nutzenbewertung nach § 35a SGB V: Apixaban [Internet]. Berlin: G-BA; [cited 2026 Oct 9]. Available from: https://www.g-ba.de/bewertungsverfahren/nutzenbewertung/
- Agencia Española de Medicamentos y Productos Sanitarios. Informes de posicionamiento terapéutico [Internet]. Madrid: AEMPS; [cited 2026 Oct 9]. Available from: https://www.aemps.gob.es/medicamentos-de-uso-humano/evaluacion-de-tecnologias-sanitarias/informes-de-posicionamiento-terapeutico/
- Ministerio de Sanidad. Nomenclátor de facturación de octubre 2026 [Internet]. Madrid: Ministerio de Sanidad; 2026 [cited 2026 Oct 9]. Available from: https://www.sanidad.gob.es/profesionales/nomenclator.do
- NHS Business Services Authority. Drug Tariff Part VIIIA, October 2026 [Internet]. Newcastle upon Tyne: NHSBSA; 2026 [cited 2026 Oct 9]. Available from: https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff/drug-tariff-part-viii
- NHS Business Services Authority. dm+d browser: NHS dictionary of medicines and devices [Internet]. Newcastle upon Tyne: NHSBSA; [updated 2026 Oct 1; cited 2026 Oct 9]. Available from: https://dmd-browser.nhsbsa.nhs.uk/